Clinical Trials Browser

Phase 2 × Stage IB-IIIB NSCLC × toripalimab × Clear all

NCT07039656 2025-08-07

Toripalimab Combined With Chemotherapy as Adjuvant Therapy for Non-small Cell Lung Cancer With or Without Prior Neoadjuvant Therapy

Phase 2 Recruiting

Stage IB-IIIB NSCLC